Merck, BMS Circling Deal With Cipla Over Sustiva Generic
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. may be nearing the end of a patent row with Cipla USA Inc. over Cipla's plans to make a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article